PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Trevigen, Inc.

Press Release


Receive press releases from Trevigen, Inc.: By Email RSS Feeds:

Trevigen Announces the Release of Four New Assay Kits for 3-D Cell Proliferation


Trevigen introduces four new 3-D cell proliferation kits, including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. These are the first standardized kits engineered for assessing the effects of compounds or genetic alteration on cell proliferation in 3-D culture.

Gaithersburg, MD, June 07, 2008 --(PR.com)-- Many scientists are converting from growing cells in a traditional 2-D Monolayer on plastic surfaces with tissue culture medium to “3-D” Culture. In 3-D Culture, cells are grown in a microenvironment of specialized proteins which mimics in vivo conditions and allows the cells to organize into complex structures rather than uniform monolayers. Various types of cells require different specialized proteins for optimal growth conditions and these extracellular matrices can play an important role in modulating cellular response to pharmacological compounds. For these reasons, conversion to 3-D culture with different matrices is highly desirable, but until now there has not been a practical way to evaluate cell proliferation from 3-D cultures.

Trevigen has an innovative solution with the introduction of four new 3-D cell proliferation kits including a core kit and three different kits containing basement membrane extract, laminin I, and collagen I. These are the first standardized kits engineered for assessing the effects of compounds or genetic alteration on cell proliferation in 3-D culture. The high throughput 96 stripwell formats allow one step quantitative analysis and colorimetric detection. Protocols are provided for tumorgenicity and cytotoxicity.

Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior. Trevigen has been a long-standing provider of quality reagents and kits for researchers investigating programmed cell death and DNA damage and repair. A logical extension of the focus on cancer research has been the recent development of assays for cancer cell function and behavior including angiogenesis, cell invasion and tumor formation. Currently, the product portfolio contains over 500 products categorized into four processes – Apoptosis, DNA Damage and Repair, Angiogenesis, and Oxidative Stress. 3-D qualified BME, Laminin I and Collagen I are also available separately from Trevigen. Visit www.trevigen.com or contact us at 1800-873-8443 or info@trevigen.com for more information.

###
Contact Information
Trevigen, Inc.
Belinda De Leon
1-800-TREVIGEN
Contact
www.trevigen.com
8405 Helgerman Ct.
Gaithersburg, MD 20877

Click here to view the list of recent Press Releases from Trevigen, Inc.
Promote Your Business